StockData
BioAtla, Inc. logo

BioAtla, Inc. (BCAB) stock

BCABOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$1.31−0.05 (-3.68%)

Close on Oct 19, 2026Market cap $2.18MP/E –Yield –

BioAtla market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

BioAtla's market cap was $2.18M on Oct 19, 2026, against $41.07M a year earlier. Over the last 5 years it ranged from $2.16M to $888.56M, with a median of $85.54M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$2.18M-93.5%
2025Dec 31, 2025$33.38M+16.8%
2024Dec 31, 2024$28.58M-75.7%
2023Dec 29, 2023$117.85M-60.7%
2022Dec 30, 2022$300.01M-56.6%
2021Dec 31, 2021$690.79M–

More BioAtla figures

See a number that looks wrong?